MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617004316 A) filed by Neurawell Therapeutics on January 16, 2026, for Combination Treatments For Depression And Other Disorders.
Inventors include Abraham, Magid; Satterly, Kelsey; and Mason, Jay.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The invention provides dosage forms that contain both a monoamine oxidase inhibitor (MAOI) and a beta blocker (e.g., propranolol, metoprolol, carvedilol, timolol, carteolol, atenolol, nebivolol, sotalol, bucindolol, nadalol, celirpolol, nebivolol, betaxolol, esmolol, bisoprolol, oxprenolol, penbutolol, labetalol, acebutolol, and pindolol) and methods of making and using same in, for example, for the treatment of psychiatric disorders (e.g., depression, major depressive disorder, major depressive disorder with anxious distress, treatment resistant depression, anxious depression, and mixed anxiety and depression). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Disclaimer: Curated by HT Syndication.
